HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mycophenolate in dermatology.

Abstract
Originally used to treat psoriasis nearly three decades ago, mycophenolic acid, reformulated as mycophenolate mofetil (MMF), has been rediscovered by the world of dermatology. As a relatively well-tolerated immunosuppressive used in organ transplant recipients, MMF has recently been reported to show promise for several dermatologic conditions, including psoriasis, pemphigus vulgaris, pyoderma gangrenosum, bullous lichen planus, and even connective tissue diseases such as lupus erythematosus and dermatomyositis. Although not intended to be exhaustive, this review discusses MMF with regard to its basic pharmacology, its side effects, and its reported efficacy in a variety of dermatologic indications. Relevant literature was retrieved by a Medline search combining the terms "mycophenolate" or "mycophenolic acid" and "skin" or "skin disease" or a number of specific conditions ("psoriasis", "dermatitis", "eczema", "pemphigoid", "pemphigus", "vasculitis", "pyoderma gangrenosum", "Crohn's disease", "graft-versus-host disease", "lichen planus"). As MMF has only been recently re-introduced for dermatologic application, the nature of much of the literature is admittedly that of case reports or case series. Nevertheless, the results are sufficiently promising to warrant further larger, control studies.
AuthorsV Liu, B T Mackool
JournalThe Journal of dermatological treatment (J Dermatolog Treat) Vol. 14 Issue 4 Pg. 203-11 (Dec 2003) ISSN: 0954-6634 [Print] England
PMID14660264 (Publication Type: Journal Article, Review)
Chemical References
  • Mycophenolic Acid
Topics
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Eczema (drug therapy)
  • Female
  • Graft vs Host Disease
  • Humans
  • Lichen Planus (drug therapy)
  • Male
  • Mycophenolic Acid (adverse effects, analogs & derivatives, pharmacology, therapeutic use)
  • Pregnancy
  • Psoriasis (drug therapy)
  • Pyoderma Gangrenosum (drug therapy)
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Skin Diseases (diagnosis, drug therapy)
  • Skin Diseases, Vesiculobullous (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: